Rare diseases
Investigational molecules
Locations
Back to Belgium5 clinical trials in Saint-Nicolas, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Atogepant for Treating Migraine in Patients: Evaluating Effectiveness and Safety
BelgiumStudy of Erenumab Compared to Placebo for Children and Adolescents with Episodic Migraine to Reduce Monthly Migraine Days
BelgiumA Study of Erenumab Compared to Placebo for Children and Teenagers With Chronic Migraine to Test How Well It Works and How Safe It Is
BelgiumStudy on Rimegepant for Treating Migraine in Adults Who Cannot Use Triptans
BelgiumStudy on Rimegepant for Preventing Migraines in Adults with Poor Response to Oral Preventive Medications
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies focusing on acute migraine treatment and preventive therapies, evaluating novel medications for patients experiencing migraine attacks with or without aura.
Research aims to improve treatment options for those with inadequate response to conventional medications.
Clinical investigations examining the effectiveness of new therapeutic agents for both single-attack treatment and long-term migraine prevention.
These trials evaluate both immediate relief and sustained preventive benefits for migraine sufferers.
Research focusing on developing targeted therapies for patients who have shown insufficient response to standard migraine treatments.
Studies aim to expand treatment options for diverse patient populations with varying migraine presentations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
